Rapid communication Open Access
Like 0


We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.1.5 vaccine against COVID-19 hospitalisation and admission to an intensive care unit (ICU) in previously vaccinated adults ≥ 60 years in the Netherlands. We compared vaccination status of 2,050 hospitalisations including 92 ICU admissions with age group-, sex-, region- and date-specific population vaccination coverage between 9 October and 5 December 2023. VE against hospitalisation was 70.7% (95% CI: 66.6–74.3), VE against ICU admission was 73.3% (95% CI: 42.2–87.6).


Article metrics loading...

Loading full text...

Full text loading...



  1. National Institute for Public Health and the Environment (RIVM). Deelname COVID-19-vaccinatie in Nederland (19 december 2023) [Uptake of COVID-19 vaccination in the Netherlands (19 December 2023)]. Bilthoven: RIVM; 2023. [Dutch]. Available from: https://www.rivm.nl/corona/actueel/vaccinatiecijfers/update-deelname-covid-19-vaccinatie-in-nederland
  2. Government of the Netherlands. Coronavirus Dashboard. Virus particles in wastewater. The Hague: Rijksoverheid. [Accessed: 20 Dec 2023]. Available from: https://coronadashboard.government.nl/landelijk/rioolwater
  3. Government of the Netherlands. Coronavirus Dashboard. View on the hospitals. The Hague: Rijksoverheid. [Accessed: 12 Dec 2023]. Available from: https://coronadashboard.government.nl/landelijk/ziekenhuizen-in-beeld
  4. Van Werkhoven CH, De Gier B, McDonald SA, De Melker HE, Hahne SJM, Van den Hof S, et al. Information bias of vaccine effectiveness estimation due to informed consent for national registration of COVID-19 vaccination: estimation and correction using a data augmentation model. medRxiv. 2023:2023.05.23.23290384 . https://doi.org/10.1101/2023.05.23.23290384 
  5. National Institute for Public Health and the Environment (RIVM). Uitvoeringsrichtlijn COVID-19-vaccinatie, versie 5.1 (8 december 2023). [COVID-19 guideline version 5.1 (8 December 2023)]. Bilthoven: RIVM; 2023. Dutch. Available from: https://lci.rivm.nl/richtlijnen/covid-19-vaccinatie
  6. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 2023;52(1):14-21.  https://doi.org/10.1093/ije/dyac207  PMID: 36326585 
  7. National Institute for Public Health and the Environment (RIVM) COVID-19 Epidemiology and Surveillance Team. COVID-19 ziekenhuis en intensive-care-opnames per vaccinatiestatus in Nederland (opnames 3 oktober 2022 – 12 december 2022). [COVID-19 hospitalisations and intensive care unit admissions by vaccination status in the Netherlands (admissions 3 October 2022–12 December 2022)]. Bilthoven: RIVM; 2022. [Dutch]. Available from: https://www.rivm.nl/documenten/covid-19-ziekenhuis-en-intensive-care-opnames-per-vaccinatiestatus-in-nederland-4
  8. de Gier B, van Asten L, Boere TM, van Roon A, van Roekel C, Pijpers J, et al. Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021-January 2022. Vaccine. 2023;41(31):4488-96.  https://doi.org/10.1016/j.vaccine.2023.06.005  PMID: 37328352 
  9. Hansen CH, Moustsen-Helms IR, Rasmussen M, Soborg B, Valentiner-Branth P, Ullum H. Effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation: a nation-wide cohort study in Denmark, October 2023. Rochester: SSRN; 2023. Preprint.  https://doi.org/http://dx.doi.org/10.2139/ssrn.4627268 
  10. European Centre for Disease Prevention and Control (ECDC). Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/publications-data/interim-analysis-covid-19-vaccine-effectiveness-against-hospitalisation-and-death

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error